N/A

1. van Maaren MC, Voorham QJM, Wijnen EM, de Munck L, Wesseling J, Visser O, Siesling S. Notification of locoregional breast cancer recurrence based on pathology reports: A nationwide validation study with the Netherlands Cancer Registry. Cancer Epidemiol. 2025 Mar 5;96:102780. doi: 10.1016/j.canep.2025.102780. Epub ahead of print.

2. Kuijper SC, Gehrels AM, van der Geest LG, Verhoeven RHA, Koerkamp BG, Molenaar IQ, Stommel MWJ, de Meijer VE, de Vos-Geelen J, Wumkes ML, Besselink MG, Wilmink JW, van Laarhoven HWM; Dutch Pancreatic Cancer Group. Survival scenarios of patients with localized and metastatic pancreatic adenocarcinoma: A population-based study. Int J Cancer. 2025 May 1;156(9):1726-1735.

3. Darai A, Koëter T, van Erning FN, van Alphen RJ, Verheul HMW, Verheij M, Zimmerman DDE, Vissers PAJ, de Wilt JHW. The role of adjuvant chemotherapy in rectal cancer: A nationwide cohort study from the Netherlands. Colorectal Dis. 2025 Mar;27(3):e70054.

4. Jutten E, van Kempen LCLT, Diercks GFH, van Leeuwen BL, Kruijff S, Wevers KP. Real-World Evidence of the Prevalence of Driver Mutations in Anorectal Melanoma. Mol Diagn Ther. 2025 Mar;29(2):229-238.

5. Galanos LJK, Rijken A, Elferink MAG, Kok NFM, van Erning FN, De Hingh IHJT. Influence of a nationwide colorectal cancer screening program on the incidence of synchronous colorectal peritoneal metastases. Int J Cancer. 2025 Feb 17. doi: 10.1002/ijc.35356. Epub ahead of print.

6. Yildirim H, Richters A, Bins AD, Postema AW, Aarts MJB, van Oijen MGH, Zondervan PJ, Aben KKH. Immunotherapy in metastatic renal cell carcinoma: Insights from a Dutch nationwide cohort. Eur Urol Open Sci. 2025 Feb 10;72:42-45.

7. van Doorn-Wink KCJ, Postmus PE, de Ruysscher D, Damhuis RAM. Ninety-day mortality following curative intent radiotherapy for stage I-III lung cancer in the Netherlands. Radiother Oncol. 2025 Feb;203:110661.

8. van Laarhoven H, Verhoeven R, van Berge Henegouwen M, Mohammad NH, van Hillegersberg R, Slingerland M, Muijs CT, Wijnhoven B, Mostert B, Beerepoot L, Nieuwenhuijzen G, Derks S, van Rossum PSN. Real-world outcomes of the CROSS regimen in patients with resectable esophageal or gastro-esophageal junction adenocarcinoma: a nationwide cohort study in the Netherlands. EClinicalMedicine. 2025 Jan 22;80:103067.

9. Westerveld ASR, Tytgat GAM, van Santen HM, van Noesel MM, Loonen J, de Vries ACH, Louwerens M, Koopman MMW, van der Heiden-van der Loo M, Janssens GO, de Krijger RR, Ronckers CM, van der Pal HJH, Kremer LCM, Teepen JC. Long-Term Risk of Subsequent Neoplasms in 5-Year Survivors of Childhood Neuroblastoma: A Dutch Childhood Cancer Survivor Study-LATER 3 Study. J Clin Oncol. 2025 Jan 10;43(2):154-166.

10. Mülder DT, van de Schootbrugge-Vandermeer HJ, O'Mahony JF, Sun D, Han W, Verhoeven RHA, van Loo M, van de Veerdonk W, Spaander MCW, Lansdorp-Vogelaar I. Gastric Cancer Risk among Immigrants and Socioeconomic Groups in the Netherlands. Cancer Epidemiol Biomarkers Prev. 2025 Jan 9;34(1):85-92.

1. Beecroft S, O’Connell M, Nassar A, Noon K, Pollock KG, Palmer D, Cross TJ. Major variation in hepatocellular carcinoma treatment and outcomes in England: a retrospective cohort study. Frontline Gastroenterology. 2023 Jan 1;14(1):19-24.

2. Cox T, O’Connell M, Leeuwenkamp O, Palimaka S, Reed N. Real-world comparison of healthcare resource utilization and costs of [177Lu] Lu-DOTA-TATE in patients with progressive neuroendocrine tumors in England: a matched cohort analysis using data from the hospital episode statistics dataset. Current Medical Research and Opinion. 2022 Aug 3;38(8):1305-17.

3. Yakutcan U, Demir E, Hurst JR, Taylor PC, Ridsdale HA. Operational modeling with health economics to support decision making for copd patients. Health Services Research. 2021 Dec;56(6):1271-80.

4. Shah A, Hawley S, Inman DS, Cooper C, Fagan E, Johansen A, Judge A. Geographical variation in surgical care and mortality following hip fracture in England: a cohort study using the National Hip Fracture Database (NHFD). Osteoporosis International. 2021 Oct 1:1-0.

5. Parry-Smith W, Okoth K, Subramanian A, Gokhale KM, Chandan JS, Humpston C, Coomarasamy A, Nirantharakumar K, Šumilo D. Postpartum haemorrhage and risk of mental ill health: A population-based longitudinal study using linked primary and secondary care databases. J Psychiatr Res. 2021 May;137:419-425. 

6. Keltie K, Cognigni P, Gross S, Urwin S, Burn J, Cole H, Berry L, Patrick H, Sims A. Comparison of identifiable and non-identifiable data linkage: health technology assessment of MitraClip using registry, administrative and mortality datasets. BMJ Health Care Inform. 2021 Apr;28(1):e100223. 

7. Baskaran V, Pearce F, Harwood RH, McKeever TM, Lim WS. Primary care consultations after hospitalisation for pneumonia: a large population-based cohort study. Br J Gen Pract. 2021 Mar 26;71(705):e250-e257. 

8. Bhamra N, Osborne MS, Balai E, Jolly K, Barraclough J. Prevalence of Patients Who Return to Theatre Post-Adenoidectomy: A Review of Hospital Episode Statistics Data (2012-2019). Cureus. 2021 Mar 18;13(3):e13980.

9. Stephens S, Chatterjee A, Coles V, Crawford R. The costs of treating vaginal and vulval cancer in England (2009–2015). BMC Public Health. 2020 Dec;20(1):1-8.

10. De Oliveira H, Prodel M, Lamarsalle L, Inada-Kim M, Ajayi K, Wilkins J, Sekelj S, Beecroft S, Snow S, Slater R, Orlowski A. “Bow-tie” optimal pathway discovery analysis of sepsis hospital admissions using the Hospital Episode Statistics database in England. JAMIA open. 2020 Oct;3(3):439-48.